Brind.
  1. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
  2. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
  3. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
  4. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.

Recursion Pharmaceuticals, Merck KGaA, and Tempus expanded collaborations to leverage multimodal datasets and launch AI models for drug discovery.

1 report, 1 independent Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Recursion Pharmaceuticals, Merck KGaA, and Tempus expanded collaborations to leverage multimodal datasets and launch AI models for drug discovery.

Who's involved

What this event is mainly about
Merck KGaATempusRecursion (United States)

Keep exploring

Part of

Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.

Also in this story

All 12 developments

Within Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyRecursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition We recently published 10 Best Biotech Stocks to Buy Under $10. Recursion Pharmaceuticals, Inc. is placed e